MAP2K7 and melanoma: Of note, overexpression of miR-579-3p was able to prevent colony formation in cells exposed to vemurafenib and impair the growth of BRAFi-resistant melanoma cells in combination with the MEK inhibitor (MEKi) trametinib [125].